Risk Factors for Local Anesthetic Systemic Toxicity (LAST)
The primary risk factor for LAST is excessive dosing of local anesthetic, particularly exceeding maximum recommended doses (e.g., >9 mg/kg lean body weight for lidocaine), with inadvertent intravascular injection being the most dangerous mechanism of toxicity. 1, 2
Patient-Specific Risk Factors
High-Risk Populations
- Extremes of age: Infants and elderly patients are at significantly increased risk due to altered pharmacokinetics and reduced drug clearance 3, 4
- Hepatic dysfunction: Patients with severe liver disease cannot metabolize amide-type local anesthetics normally, leading to toxic plasma concentrations 2
- Cardiovascular disease: Patients with impaired cardiac function are less able to compensate for the cardiovascular effects of local anesthetics 2
- Low cardiac output states: Reduced perfusion decreases drug distribution and increases systemic concentration 3
Vulnerable Patient Characteristics
- Debilitated or acutely ill patients require reduced doses commensurate with their physical status 2
- Patients with severe shock or heart block are at higher risk for cardiovascular collapse 2
Drug and Dosing Risk Factors
Excessive Dosing
- Exceeding maximum recommended doses is a critical risk factor: lidocaine >9 mg/kg lean body weight with epinephrine or >4.5 mg/kg without epinephrine 1, 5
- Repeated doses cause significant increases in blood levels with each administration due to slow drug accumulation 2
- Rapid injection increases peak plasma concentrations and toxicity risk 1, 3
High-Potency Agents
- Bupivacaine is the most frequently implicated agent in severe LAST with cardiovascular collapse due to profound sodium channel blockade 6
- Higher concentrations of local anesthetics may provide faster onset but carry greater toxicity risk 1
Technical and Procedural Risk Factors
Injection Technique
- Inadvertent intravascular injection (intra-arterial or intravenous) is the most dangerous mechanism, delivering high concentrations directly into circulation 2, 4
- Head and neck blocks (retrobulbar, dental, stellate ganglion) carry particular risk due to potential retrograde cerebral circulation 2
- Invasive nerve blocks (glossopharyngeal, superior laryngeal) are associated with higher plasma concentrations and increased LAST risk 1
Anatomic Considerations
- Highly vascular injection sites increase systemic absorption rates 3, 4
- Areas with compromised blood supply may lead to delayed absorption followed by sudden release 2
Monitoring and Preparation Deficiencies
Lack of Preparedness
- Absence of lipid emulsion immediately available at the bedside delays life-saving treatment 7
- Inadequate monitoring of cardiovascular and respiratory status during and after injection 2
- Failure to fractionate doses or perform aspiration testing before injection 3
Critical Prevention Strategies
- Calculate maximum safe dose before injection based on lean body weight, not total body weight 1, 7
- Use ultrasound guidance for regional blocks to avoid intravascular injection 1, 4, 8
- Inject slowly with frequent aspiration to detect intravascular placement 1, 3
- Add epinephrine 10-15 μg as an intravascular marker to detect systemic absorption 1
- Consider using lower-toxicity agents such as ropivacaine or levobupivacaine instead of bupivacaine 3
- Have 20% lipid emulsion, resuscitation equipment, and benzodiazepines immediately available before starting any regional anesthetic procedure 7, 3